奥力欣品牌怎么样申请店铺

我要投票

奥力欣在兽药行业中的票数：729 更新时间：2026-04-13

奥力欣是哪个国家的品牌？「奥力欣」是安徽奥力欣生物科技有限公司旗下著名品牌。该品牌发源于安徽省安庆市，由创始人丁国平在2002-08-09期间创立，经过多年的不懈努力和高速发展，现已成为行业的标杆品牌。

外推网助力奥力欣品牌出海！将品牌入驻外推网，定制奥力欣品牌推广信息，可以显著提高奥力欣产品曝光，简直是跨境电商爆单神器！目前仅需1000元/年哦~

安徽奥力欣生物科技有限公司成立于2002年，是集生物技术开发、饲料添加剂、兽药研发等加工生产、销售为一体企业。公司法定代表人丁国平，注册资本6000万元，专注于生物技术、兽用药物、动保用品、饲料及添加剂的研发、生产、技术服务和市场营销，在中兽制药尤其是在新剂型、新技术领域拥有雄厚的技术力量和新产品开发能力。

公司拥有兽医药、制药工程等专业人才60余人，其中博士、硕士10人；拥有自主知识产权的新产品8个，兽药新品种60余种；现厂房设施总建筑面积56000㎡，制药生产、检测设备400余台套。质检中心设有理化室、仪器分析室、中药室，配备有液相色谱仪、分光光度计等精密仪器，设施、设备优良、齐全。公司在充分发挥自身技术优势同时，利用外脑资源，与国内多个研究机构进行合作，研发的新药品种如“禽呼吸道病防治合剂”、“芪根可溶性粉”等多个国家Ⅲ类新兽药，临效显著。

目前奥力欣企业技术中心、兽用药物生物工程中心已经逐步实施运营，企业后续将以双中心为依托，以“奥力欣中药科技产业化项目”为契机，着眼于中兽药的研发、生产和营销，夯实基础，以人为本，专注于公司企业文化的建设和管理，同时专注于奥力欣品牌的打造与创新，以逐步建成动物疾病研究硕士工作站、国家技术研究中心等。伴随着全球经济一体化的时代趋势和当前公司制定的战略规划，奥力欣未来5年的展望：“打造中兽药奥力欣®品牌, 成为国内兽用药物产品市场带领者”，在新形势下实现步发展。

Anhui aolixin Biotechnology Co., Ltd. was founded in 2002. It is an enterprise integrating the processing, production and sales of biotechnology development, feed additives, veterinary medicine research and development. Ding Guoping, the legal representative of the company, with a registered capital of 60 million yuan, focuses on the R & D, production, technical service and marketing of biotechnology, veterinary drugs, animal protection products, feed and additives, and has strong technical force and new product development capacity in China veterinary pharmaceutical, especially in the field of new dosage forms and new technologies. The company has more than 60 professional talents in veterinary medicine, pharmaceutical engineering, etc., including 10 doctors and masters; 8 new products with independent intellectual property rights, more than 60 new varieties of veterinary medicine; the total building area of plant facilities is 56000m2, and more than 400 sets of pharmaceutical production and testing equipment. The quality inspection center is equipped with physical and chemical room, instrument analysis room, Chinese medicine room, liquid chromatograph, spectrophotometer and other precision instruments, with excellent facilities and complete equipment. At the same time, the company makes full use of its own technical advantages, uses external brain resources, and cooperates with a number of domestic research institutions to develop new drug varieties such as "bird respiratory disease prevention and treatment mixture", "Qigen soluble powder" and other national class III new veterinary drugs with significant clinical effects. At present, aolixin enterprise technology center and veterinary medicine bioengineering center have been gradually put into operation. In the future, the enterprise will rely on the two centers and take the opportunity of "aolixin TCM technology industrialization project", focus on the R & D, production and marketing of Chinese veterinary medicine, consolidate the foundation, people-oriented, focus on the construction and management of corporate culture, and focus on the brand of aolixin Build and innovate to gradually build master's workstation of animal disease research, national technology research center, etc. With the trend of global economic integration and the current strategic plan formulated by the company, alixin's outlook for the next five years: "to build the brand of Chinese veterinary drug alixin, and become the market leader of domestic veterinary drug products", and realize further development in the new situation.

本文链接： https://brand.waitui.com/d905db3bd.html 联系电话：请联系客服添加联系邮箱：请联系客服添加